Pharmacokinetics of verinurad and allopurinol in combination with cyclosporine and rifampicin in healthy volunteers

Trial Identifier: D5495C00013
Sponsor: AstraZeneca
Parexel International
NCTID:: NCT04532918
Start Date: September 2020
Primary Completion Date: November 2020
Study Completion Date: November 2020
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050